"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
A prospective interventional trial for 9 months will be carried out on 300 type-2 diabetes
mellitus volunteer patients who are above 18-year-old and participants will be selected
through consecutive sampling and will be evaluated on the basis of glycemic index and history
of patients. Selected parameters will be measured at baseline and after the 12 weeks of
therapy. Statistical analysis will be carried out by SPSS, ANOVA, and t-test.
From this experimental design, we are expecting improvement in the management of glycemic
index, reduction in systolic and diastolic blood pressure, and reduction in weight GLP-1
naive patients.